Font Size: a A A
Keyword [Lung Cancer Patients]
Result: 1 - 20 | Page: 1 of 10
1. Studying DNA Repair Capacity And Checkpoint Gene Protein (ATM Protein) Of Lung Cancer Patients And Breast Cancer Patients
2. Expression Of Polymeric Immunoglobulin Receptor (PIGR/SC) In The Tumor Tissues And The Plasma Levels Of Lung Cancer Patients
3. Mitochondral DNA Mutations In Lung Cancer And Mitochodrial DNA Polymorphisms In Chinese Lung Cancer Patients.
4. The Protein Overexpression Of The Tumor Suppressor Gene P53 And Prognosis In Lung Cancer Patients Surgically Treated
5. Detection Of Rb2/p130 And P53 Gene Mutations By DHPLC Analysis In Chinese Lung Cancer Patients And Its Clinical Implications
6. The Value Of Detecting P53, K-ras Genes And Their Products To The Diagnosis Of Lung Cancer Patients
7. Association Between ERCC6-6530 Single Nucleotide Polymorphism And Prognosis Of Small Cell Lung Cancer Patients Treated With Platinum-based Chemotherapy
8. Clinical And Experimental Research On The Effectiveness Of Using "Xian Yu Tang" Chinese Medicine To Improve Quality Of Life For Elder Lung Cancer Patients
9. A Study On The Relation Of ERCC1 Expression And The Clinical Features, Prognosis And Cis-Platinum Adjuvant Chemotherapy In Non-Small Cell Lung Cancer Patients
10. Clinical And Laboratory Study On Factors Associated With Radiation-induced-Lung-Injury And Survival Of Lung Cancer Patients
11. Association Between Polymorphisms In Genes Involved In Apoptosis And Drug Metabolism And The Clinical Outcome In Advanced Non-Small-Cell Lung Cancer Patients Treated With Gefitinib
12. Clinical Significance Of Expression Of ERCC1, Class Ⅲ β Tubulin In Resected Patients With Non-small Cell Lung Cancer & Association Between Polymorphisms Of ERCC1 And Response And Survival In Advanced Non-small Cell Lung Cancer Patients Treated With Cis
13. Non-invasive Visualization Of The Epidermal Growth Factor Receptor In Non-small Cell Lung Cancer Patients By Positron Emission Tomography And 11C-PD153035
14. The Changes Of CD4~+CD25~+ Regulatory T Cells Of Non Small-cell Lung Cancer Patients And The Effects Of CpG ODN
15. Diagnotic Significant Of The Combined Determination Of P53 Mutation And Telomerase Activity For Lung Cancer Patients
16. Proteomic Profiling Of Candidate Biomarkers In Urine Of Non-Small Cell Lung Cancer Patients
17. Analysis Of Immune-related Gene Expression Changes In Tuberculosis And Lung Cancer Patients
18. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (gefitinib) In China With Advanced Non-small Cell Lung Cancer Patients In The Efficacy And Safety Studies And Clinical Efficacy Predictors
19. Preliminary Study Of Diagnosis And Treatment In Acute Lung Injury, And Pharmacogenetic Assessment Of Leukopenia After Platinum Chemotherapy In Non-small Cell Lung Cancer Patients
20. Clinical And Laboratory Study Of The Method "Invigorating Qi And Expel Ling Phlegm" On Non-Small Cell Lung Cancer Patients
  <<First  <Prev  Next>  Last>>  Jump to